Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 20.0-75.0,  Metabolic Syndrome Overweight Obesity Hypercholesterolemia BMI ≥25 and <45 LDL >100 mg/dl TG ≥150 and <400 mg/dl meet 2 or more of the following 4 HDL <50 mg/dl blood pressure ≥130/85 mmHg (or diagnosed hypertension on medication) fasting glucose ≥100 mg/dl and <150 mg/dl waist circumference >35 inches  Medical History and Concurrent Diseases 1. Over the preceding 4 weeks, initiation or cessation of regular exercise 2. Over the preceding 4 weeks, involvement in a significant diet or weight loss program such as Atkin's diet program, a very low calorie liquid program (such as Optifast, Medifast, and HMR), or any diet that has led to a weight loss of 10% of body weight over a period of 6 weeks 3. Use of blood sugar lowering medications including thiazolidinedione class of oral medications including Avandia (rosiglitazone), Avandamet (metformin/rosiglitazone), Actos (pioglitazone), metformin (Glucophage, Fortamet, Riomet) or insulin over the preceding 12 weeks 4. Over the preceding 4 weeks, regular use of Kaprex® or Kaprex AI® at least 3 days/week 5. Over the preceding 4 weeks, regular use of NSAIDs (i.e. ibuprofen, celecoxib, etc.) at least 3 days per week 6. Over the preceding 12 weeks, use of cholesterol lowering medications, either by prescription (statins, etc.) or over-the-counter (gugulipids, niacin, etc.) 7. Over the preceding 12 weeks, use of oral or injectable corticosteroids, such as prednisone 8. Current use of oral anticoagulants such as Coumadin or injectable anticoagulants such as Heparin or Low Molecular Weight Heparin 9. Use of electronic implants such as pacemakers, defibrillators, nerve stimulators 10. Allergy to one or more of the ingredients in the investigational products 11. Poorly controlled hypertension (blood pressure above 155/95) 12. History of significant liver or kidney disease (recent or ongoing hepatitis, cirrhosis, glomerulonephritis, dialysis treatment, etc.) 13. History of serious heart disease (heart attack, angina, cardiac surgery, arrhythmia, or congestive heart failure) 14. History of deep vein thrombosis or pulmonary embolus (blood clot to lungs) 15. History of autoimmune diseases such as inflammatory bowel disease (Crohn's disease, and/or ulcerative colitis), multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, polymyositis, scleroderma and thyroiditis 16. History of eating disorder (anorexia nervosa or bulimia) in preceding 5 years 17. History of alcoholism or drug addiction in the preceding 5 years 18. History of serious mental illness 19. History of attempted suicide in past 10 years 20. Untreated endocrine, neurological, or infectious disorder 21. Diagnosis of Human Immunodeficiency Virus (HIV) or Acquired HIV (AIDS) 22. Current cancer or a history of cancer (except skin cancer) 23. Pregnancy or lactation 24. If female of childbearing potential, unwillingness to practice a reliable method of birth control (i.e. physical sperm barriers or hormonal therapies) 25. Any other sound medical, psychiatric and/or social reason as determined by the Principal Investigator (PI) Physical and Laboratory Test Findings 1. TG ≥ 400 mg/dl 2. abnormal blood count (Hct < 30 or > 47%, WBC < 3,000 or > 12,000, platelets <140 or > 500) 3. abnormal kidney function test(s) (BUN > 30 mg/dL or creatinine > 1.5 mg/dL) or liver function test(s) (bilirubin total > 2.0 mg/dL, ALT > 75 IU/L, AST > 75 IU/L; Alk Phos > 130 IU) 4. fasting glucose >150 mg/dL, serum calcium (>10.5 mg/dL), positive pregnancy test (ß-hCG in blood)